Redeemer Health

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer3 trials
• Lung cancer3 trials
• Ovarian cancer3 trials
• Bladder cancer2 trials
• Childhood cancers2 trials
• Gastric and oesophageal cancer2 trials
• Kidney cancer2 trials
• Melanoma2 trials
• Metastatic breast cancer2 trials
• Multiple myeloma2 trials
• Pancreatic cancer2 trials
• Prostate cancer2 trials
• and 9 more

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Recruiting4 trials
• Active, not recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• National Cancer Institute (NCI)4 trials
• Alliance for Clinical Trials in Oncology3 trials
• NRG Oncology1 trial
• SWOG Cancer Research Network1 trial

Running trials

• Recruiting

  Family Communications After Genetic Testing

  NCT07143487· Alliance for Clinical Trials in Oncology· Source

  Contact: Leigh Gerson (principal investigator)

• Recruiting

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· Phase 3· NRG Oncology· Source

  Contact: Rabia Cattie (principal investigator)

• Recruiting

  Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

  NCT05929768· Phase 3· SWOG Cancer Research Network· Source

  Contact: Danny Markabawi (principal investigator)

• Recruiting

  Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  NCT05334069· Alliance for Clinical Trials in Oncology· Source

  Contact: Marie Wood, MD

• Active, not recruiting

  NCI COVID-19 in Cancer Patients, NCCAPS Study

  NCT04387656· National Cancer Institute (NCI)· Source

• Recruiting

  Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  NCT04242095· Alliance for Clinical Trials in Oncology· Source

  Contact: Rabia Cattie (principal investigator)

• Active, not recruiting

  Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

  NCT02465060· Phase 2· National Cancer Institute (NCI)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Ovarian cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Terminated

  Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

  NCT03199885· Phase 3· National Cancer Institute (NCI)· Source

• Completed

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· Phase 3· National Cancer Institute (NCI)· Source